Physician profile
Timothy A Bednar
NPI 1699058719
$28,154.05
in general payments reported to CMS, 2019-2025
12 companies · $2,929 in 2025
The $2,929 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,267 · 2020: $3,632 · 2021: $5,236 · 2022: $5,721 · 2023: $3,191 · 2024: $4,178 · 2025: $2,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,600 · Travel and Lodging: $684 · Education: $14.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,599.80 |
| Travel and Lodging | $684.29 |
| Education | $14.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22,674.18 | 2019-2025 | Proclaim, Octrode, Eterna |
| Spinal Simplicity, LLC | $1,907.05 | 2021-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $1,591.56 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $1,173.92 | 2021-2025 | Intracept |
| Painteq LLC | $320.35 | 2023-2024 | Painteq |
| Vertos Medical, INC. | $149.48 | 2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $138.25 | 2022-2023 | Intracept |
| Hydrocision, INC. | $113.17 | 2022 | |
| Spr Therapeutics, INC | $47.32 | 2023 | Sprint Pns System |
| Abbvie INC. | $13.28 | 2024 | |
| Stimwave Technologies Incorporated | $13.13 | 2020 | |
| Depuy Synthes Sales INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bednar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.